Sunday, 28 October 2012

'The NeuroAD system by Neuronix is an innovative, safe and effective non-pharmaceutical treatment alternative with technology that is CE-approved for the treatment of mild to moderate Alzheimer’s Disease. 

It is the first medical device technology in the world cleared for this indication and has shown to deliver lasting improvement in cognitive ability of patients, as well as modify disease progression. 

The neuroAD system is based on Neuronix’s patent-pending Non Invasive Cortical Enhancer (NICE™) technology. This patent-pending technology combines two modalities concurrently: 
the course of disease progression.'